Status:
RECRUITING
To Establish a Molecular Typing System for Early Diagnosis of Lung Cancer
Lead Sponsor:
Singlera Genomics Inc.
Collaborating Sponsors:
China-Japan Friendship Hospital
Conditions:
Lung Cancer
Eligibility:
All Genders
18-75 years
Brief Summary
This topic to take large multicenter study real world, the advanced liquid biopsy will ctDNA methylation detection technique is applied to pulmonary nodules differential diagnosis and early lung cance...
Detailed Description
1. All patients underwent low-dose CT pulmonary nodule AI detection and peripheral blood ctDNA methylation detection at baseline 2. Follow-up plan: Low-risk and medium-risk nodules and some high-risk ...
Eligibility Criteria
Inclusion
- Patients with pulmonary nodules confirmed by chest CT are not limited to single nodules;
- Nodule diameter 5-30mm
- Nodules include solid, semi-solid and ground glass nodules;
- Age 18-75, no gender limitation;
- The newly diagnosed patients did not receive surgery, radiotherapy, chemotherapy, targeted therapy or other tumor-related interventions;
- Sign informed consent.
Exclusion
- Patients with diagnosed lung cancer and extrapulmonary malignant tumor;
- Pulmonary sarcoidosis, pulmonary vasculitis, pulmonary tuberculosis;
- Patients with poor compliance are expected to be unable to complete follow-up according to the study protocol;
- Major trauma requiring blood transfusion occurred within one week before enrollment;
- Pregnant and lactation patients.
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT05432128
Start Date
January 1 2020
End Date
December 31 2025
Last Update
April 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China, 100029